Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. - Wikidata - wikimedia - TriplyDB

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

http://www.wikidata.org/entity/Q33285352

about

Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease A chemokine self-presentation mechanism involving formation of endothelial surface microstructures Characterization of anticoagulant heparinoids by immunoprofiling.ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer Endothelial and leukocyte heparan sulfates regulate the development of allergen-induced airway remodeling in a mouse model Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation.Peptide-displaying phage technology in glycobiology Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera.Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding.Dermatan Sulfate-Free Mice Display Embryological Defects and Are Neonatal Lethal Despite Normal Lymphoid and Non-Lymphoid Organogenesis Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation Direct visualization of specifically modified extracellular glycans in living animals.Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity.Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell.Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Extracellular sugar modifications provide instructive and cell-specific information for axon-guidance choices Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation.A transgenic approach to live imaging of heparan sulfate modification patterns.Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.Expression of heparan sulfate proteoglycans in murine models of experimental colitis.Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation

P2860

Q26992202-630B7270-4F1C-4E2B-A8F4-526A6CBFA06B Q30540297-8A74363E-FA4C-47F4-9A50-4300AB4B4CD8 Q33376879-BA3814DE-41E5-4C7A-BD81-B3E8BDFABD06 Q33506936-1828EC21-59D6-49FA-9C75-751982C5D809 Q33803148-7B595002-3A86-439E-B4BE-F1A16AD6EBCE Q33806763-46DAADCD-F1C3-44DE-8F94-A082C6D1EC8B Q33857916-61AB2F52-F483-42A8-941A-D47FDD1085FB Q34022620-B34353BE-A237-4465-BA4A-9E7C4749DC7C Q34251345-DA026D6A-9B8C-442A-A29E-992D190A7AA0 Q34412830-301767B4-2C27-42BC-A0B1-0368D804C0FC Q34757062-3A1D1488-C227-495B-922A-0DCED237E2AD Q35221119-A1D52698-66B9-42A1-8CE9-2FB8093A7A9B Q35624698-11746FCF-C4C7-4D4A-B4DE-7DA3FCA79AF0 Q35816218-80043DF9-6913-41BC-BC8D-8CDDA548DF03 Q35879491-0153149F-0320-41B4-B762-B281CCA9D775 Q36222320-D37B3F87-8C1F-4C9A-9A75-3FE17215A964 Q36517471-007FF90C-45D0-4639-86CB-890CCF89E5D2 Q37256065-5708393F-A96C-4861-AAAC-C9505AD88581 Q37335962-4D1720BE-1C3F-4E4C-9787-8731E46F06BE Q38770928-8A9610FA-930B-4D77-9779-8C15E4C1B33A Q38995855-5B5BAB79-9067-4694-9584-19ADECC2421E Q39060517-E1C9AE8B-871B-4934-BD61-429FAE164119 Q42047138-5B635DDE-A02D-46D1-9298-118E563987D5 Q42276329-77FB2763-DFA8-4CB2-BB99-E01A819523BC Q42670912-4D252AC4-E654-4A28-A050-FA7E5EB8DC7F Q42975266-2CDCD22E-D1ED-4683-A5C9-DB1DFF26068E Q44130592-7346E499-782A-49C8-9C5F-F8F620BBFF53 Q52667051-07028D64-647B-4B34-BCC1-C320FA81E4A5 Q54344427-24467597-56D3-439C-A5A4-44FE79855BB9 Q54888139-98428B40-98BC-40D9-A6D3-FBC810E1253B

P2860

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

http://www.wikidata.org/entity/Q33285352

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@ast

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@en

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@nl

type

label

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@ast

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@en

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@nl

prefLabel

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@ast

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@en

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@nl

P1433

Q33285352-FD7966BC-4BB9-4012-9BBE-D38B7FD7A452

P1476

Q33285352-9615A081-FBCA-42A6-A420-5A743F7D2E01

P2093

Q33285352-0A4814FB-5A05-40E1-8553-0DDF9E3BF812

Q33285352-4B6EB3BF-160B-47FD-848B-D7F14E65E577

Q33285352-677DA403-CB71-4C3B-8B14-6ED38CED3862

Q33285352-6B4146CB-3F37-431E-98C1-7AEAEFA399D9

Q33285352-7217A794-845C-4C8E-9B3F-D575B215A902

Q33285352-AA7999A0-BF3B-4262-85CB-53D400340BB2

Q33285352-B685D988-16FA-44A7-A136-40D2152FA5C0

Q33285352-FE5D1391-C845-4598-96F9-0871CB76383A

P2860

Q33285352-0A0CB516-29EE-4AB9-BC7D-E8F3A093E3F9

Q33285352-13504C7E-973F-46AF-98D0-608D209E7C70

Q33285352-14E76D44-258E-4104-9E10-8B1D0892A261

Q33285352-19F20C17-78E4-453C-BBEB-D1DCA34967E1

Q33285352-1EFF0CEF-79A6-484D-B9A1-ABBDF050DEAA

Q33285352-4209C585-2303-4086-AED7-ACE884E6A9BE

Q33285352-430D2D6D-572E-414A-B8A6-07CEF4762F1A

Q33285352-49734381-5281-4BE3-A376-FA221678B4CC

Q33285352-4CCA2290-04ED-40AB-B8B7-AE425127F5D2

Q33285352-4CFA27AE-0332-43FD-ABB8-45EA16EEE2A3

P304

Q33285352-D2A2DA4F-98FB-4F34-9BCA-40D30C13F428

P31

Q33285352-B3A6DE13-3340-4B0A-B292-869520E40874

P356

Q33285352-97E7A365-3FE0-40C7-BA8F-705EEA594FA9

P407

Q33285352-AAC7C72F-B2B8-46C0-B7D3-3D58034AAB83

P433

Q33285352-45FC2A2D-D8CB-4155-9138-DEC82A214154

P478

Q33285352-CF0A07A7-810F-40F0-930B-39AFBA871F7F

P50

Q33285352-DF15853C-5F77-469C-ADA3-FC835D81B4AD

P577

Q33285352-FF0B2CC9-E542-4662-ABCA-0E3042E550E9

P698

Q33285352-D257F1D9-7190-44D7-B984-0A5C68338C50

P921

Q33285352-1B7892FB-0928-409D-8860-03A297015D11

Q33285352-7A1D775F-BCBC-40A5-8493-696DD4F87AFF

P356

P1433

Journal of Biological Chemistry

P1476

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

@en

P2093

Dorothe Spillmann

http://www.w3.org/2001/XMLSchema#string

Guido J Jenniskens

http://www.w3.org/2001/XMLSchema#string

Hiroko Habuchi

http://www.w3.org/2001/XMLSchema#string

Jin-Ping Li

http://www.w3.org/2001/XMLSchema#string

Koji Kimata

http://www.w3.org/2001/XMLSchema#string

Sindhulakshmi Kurup

http://www.w3.org/2001/XMLSchema#string

Tessa J M Wijnhoven

http://www.w3.org/2001/XMLSchema#string

Toin H van Kuppevelt

http://www.w3.org/2001/XMLSchema#string

P2860

Adenosine 5'-phosphosulfate kinase from Penicillium chrysogenum. site-directed mutagenesis at putative phosphoryl-accepting and ATP P-loop residues

Animal cell mutants defective in glycosaminoglycan biosynthesis

The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse

Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality

Order out of chaos: assembly of ligand binding sites in heparan sulfate

Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.

Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies.

3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.

Molecular diversity of heparan sulfate.

P304

21032-21042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M702073200

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17517889

http://www.w3.org/2001/XMLSchema#string

P921